Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

JAMA Intern Med. 2018 Aug 1;178(8):1120-1122. doi: 10.1001/jamainternmed.2018.1652.

Anton Pottegård¹, Sidsel Arnspang Pedersen^{1

2

3}, Sigrun Alba Johannesdottir Schmidt⁴, Lisbet Rosenkrantz Hölmich⁵, Søren Friis^{4

6

7}, David Gaist^{2

3}

¹ Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
² Department of Neurology, Odense University Hospital, Odense, Denmark.
³ Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
⁴ Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
⁵ Department of Plastic Surgery, Herlev Gentofte Hospital, Herlev, Denmark.
⁶ Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark.
⁷ Department of Public Health, University of Copenhagen, Denmark.

Abstract

This case-control study assesses the association of hydrochlorothiazide with risk of malignant melanoma among Danish adults.